To examine whether virus-specific CD8+ T cell priming by moDCs leads to enhanced protection against rechallenge, we harvested CD45.1+ effector P14 cells from WT or Ccr2−/− mice on day 8 post LCMV-Arm infection. Here, CCR2 is linked to infection.